Literature DB >> 23547112

TAK1-JNK axis mediates survival signal through Mcl1 stabilization in activated T cells.

Yasuko Hirata1, Ayano Sugie, Akio Matsuda, Satoshi Matsuda, Shigeo Koyasu.   

Abstract

TAK1, a member of MAPK kinase kinase (MAPKK-K) family, can activate JNK, p38 MAPK, and NF-κB signaling pathways. Although targeted gene disruption studies have demonstrated that TAK1 plays a critical role in T cell functions, precise functions of downstream mediators remain elusive. We used the chemical compound LL-Z1640-2, which preferentially suppressed MAPK activation but not NF-κB signal downstream of TAK1. LL-Z1640-2 blocked TCR-induced T cell proliferation and activation, confirming that a TAK1-mediated MAPK signal is essential for T cell activation. LL-Z1640-2 induced apoptosis of activated mouse splenic T cells in a caspase- and caspase-activated DNase-dependent manner. TAK1-JNK pathway, which is activated downstream of IL-2R, induced the phosphorylation of antiapoptotic protein Mcl1 in activated T cells, resulting in the stabilization of Mcl1 protein. Our data uncover that among signal transduction pathways downstream of TAK1, JNK mediates a survival program through Mcl1 stabilization downstream of IL-2R in activated T cells and that blockade of TAK1-JNK pathway can eliminate activated T cells by apoptosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23547112     DOI: 10.4049/jimmunol.1202809

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Survival and maintenance of regulatory T cells require the kinase TAK1.

Authors:  Jae-Hoon Chang; Hongbo Hu; Shao-Cong Sun
Journal:  Cell Mol Immunol       Date:  2015-04-20       Impact factor: 11.530

Review 2.  JNK Signaling: Regulation and Functions Based on Complex Protein-Protein Partnerships.

Authors:  András Zeke; Mariya Misheva; Attila Reményi; Marie A Bogoyevitch
Journal:  Microbiol Mol Biol Rev       Date:  2016-07-27       Impact factor: 11.056

3.  POSH Regulates CD4+ T Cell Differentiation and Survival.

Authors:  Cody A Cunningham; Leah N Cardwell; Yue Guan; Emma Teixeiro; Mark A Daniels
Journal:  J Immunol       Date:  2016-04-15       Impact factor: 5.422

4.  The WNT signaling pathway contributes to dectin-1-dependent inhibition of Toll-like receptor-induced inflammatory signature.

Authors:  Jamma Trinath; Sahana Holla; Kasturi Mahadik; Praveen Prakhar; Vikas Singh; Kithiganahalli Narayanaswamy Balaji
Journal:  Mol Cell Biol       Date:  2014-09-22       Impact factor: 4.272

5.  NG25, an inhibitor of transforming growth factor‑β‑activated kinase 1, ameliorates neuronal apoptosis in neonatal hypoxic‑ischemic rats.

Authors:  Hua Wang; Zhong Chen; Yu Li; Qiaoyun Ji
Journal:  Mol Med Rep       Date:  2017-11-10       Impact factor: 2.952

6.  Kinetic Heterogeneity of Cancer Cell Fractional Killing.

Authors:  Zintis Inde; Giovanni C Forcina; Kyle Denton; Scott J Dixon
Journal:  Cell Rep       Date:  2020-07-07       Impact factor: 9.423

7.  Serial single-cell genomics reveals convergent subclonal evolution of resistance as early-stage breast cancer patients progress on endocrine plus CDK4/6 therapy.

Authors:  Jason I Griffiths; Jinfeng Chen; Patrick A Cosgrove; Anne O'Dea; Priyanka Sharma; Cynthia Ma; Meghna Trivedi; Kevin Kalinsky; Kari B Wisinski; Ruth O'Regan; Issam Makhoul; Laura M Spring; Aditya Bardia; Frederick R Adler; Adam L Cohen; Jeffrey T Chang; Qamar J Khan; Andrea H Bild
Journal:  Nat Cancer       Date:  2021-06-03

8.  TNF-α-induced protein 8-like 2 negatively regulates the immune function of dendritic cells by suppressing autophagy via the TAK1/JNK pathway in septic mice.

Authors:  Shuang-Qing Liu; Chao Ren; Ren-Qi Yao; Yao Wu; Ying-Yi Luan; Ning Dong; Yong-Ming Yao
Journal:  Cell Death Dis       Date:  2021-10-30       Impact factor: 8.469

9.  An initial phase of JNK activation inhibits cell death early in the endoplasmic reticulum stress response.

Authors:  Max Brown; Natalie Strudwick; Monika Suwara; Louise K Sutcliffe; Adina D Mihai; Ahmed A Ali; Jamie N Watson; Martin Schröder
Journal:  J Cell Sci       Date:  2016-04-27       Impact factor: 5.285

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.